Phenylephrine per se or Combined with Pregabalin Ameliorates Mononeuropathic Pain in Rats

<b>Background/Objectives:</b> Neuropathic pain (NP) affects approximately 6.9–10% of the population and is inadequately managed by the current therapies, as reflected by a high number needed to treat (NNT). These data highlight the socio-economic burden of NP on healthcare. Thus, the repurposing of...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Sarah Kadhim Abbood, Nariman Essmat, Imre Boldizsár, Judit Mária Kirchlechner-Farkas, Csenger Kovácsházi, Yashar Chalabiani, Kornél Király, Ildikó Miklya, Zoltán Giricz, Laszlo G. Harsing, E. Sylvester Vizi, Mahmoud Al-Khrasani
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2026-03-01
Ráidu:	Pharmaceutics
Fáttát:	phenylephrine noradrenaline release pregabalin/phenylephrine combination neuropathic pain
Liŋkkat:	https://www.mdpi.com/1999-4923/18/3/334
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!